The most viewed presentations, reports, and documents from Immunovant.
Immunovant Phase 3 Batoclimab Thyroid Eye Disease 2022
investor_presentation
14 Pages
Immunovant 2024 J.P. Morgan Healthcare Conference Presentation
conference
23 Pages